Stereotactic ablative radiotherapy of 60 Gy in eight fractions is safe for ultracentral non‐small cell lung cancer

BACKGROUND: There is no consensus on the definition or recommended radiotherapy treatment of ultracentral non‐small cell lung cancer (NSCLC). Here, we report our institution's experience in treating ultracentral lung cancer patients with stereotactic ablative radiotherapy (SABR) of 60 Gy in eig...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Dan, Cui, Jianing, Zhao, Jun, You, Jing, Yu, Rong, Yu, Huiming, Jiang, Leilei, Li, Dongming, Xu, Bo, Shi, Anhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049487/
https://www.ncbi.nlm.nih.gov/pubmed/32012484
http://dx.doi.org/10.1111/1759-7714.13335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049487/
https://www.ncbi.nlm.nih.gov/pubmed/32012484
http://dx.doi.org/10.1111/1759-7714.13335

Ejemplares similares